39Followers on Owler
Aligos Therapeutics
Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections.
Read more
Annual Revenue
$8.2M
Employees
90
Funding
$375M
Industry
Aligos Therapeutics Competitors and Alternatives
1
3
2
Looking for similar companies to Aligos Therapeutics?
Aligos Therapeutics Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$8.2M
Aligos Therapeutics's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 5.4M. Over the last four quarters, Aligos Therapeutics's revenue has grown by 140.3%. Specifically, in Q2 2022's revenue was $3.7M; in Q1 2022, it was $2.6M; in Q4 2021, it was $ < 1M; in Q3 2021, Aligos Therapeutics's revenue was $1.5M.
Aligos Therapeutics News
Aligos Therapeutics Press Releases
Aligos Therapeutics Headquarters
1 Corporate Drive 2nd Floor
San Francisco, California94080
Driving Directions »Aligos Therapeutics Summary
ABOUT
Overview
Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections. Aligos Therapeutics was founded in 2018. Aligos Therapeutics' headquarters is located in San Francisco, Cal...CEO
Aligos Therapeutics's Co-Founder & CEO, Lawrence M. Blatt, currently has an approval rating of 90%. Aligos Therapeutics's primary competitors are NorthSea Therapeutics, Metacrine & Nimbus Therapeutics.Website
aligos.comCompetitors
View 3 Aligos Therapeutics competitors here.Acquisitions
There have been no acquisitions found related to Aligos TherapeuticsInvestments
Recent investment data cannot be found related to Aligos TherapeuticsFrequently Asked Questions about Aligos Therapeutics
When was Aligos Therapeutics founded?
Aligos Therapeutics was founded in 2018Who is Aligos Therapeutics's CEO?
Aligos Therapeutics's CEO is Lawrence M. BlattHow much revenue does Aligos Therapeutics generate?
Aligos Therapeutics generates $8.2M in revenueHow much funding does Aligos Therapeutics have?
Aligos Therapeutics has historically raised $375M in funding
Where is Aligos Therapeutics's headquarters?
Aligos Therapeutics's headquarters is in San Francisco California, USAHow many employees does Aligos Therapeutics have?
Aligos Therapeutics has 90 employeesWhat sector does Aligos Therapeutics operate in?
Aligos Therapeutics is in Pharmaceuticals, BiotechnologyWho are Aligos Therapeutics's competitors?
Aligos Therapeutics's top competitors are NorthSea Therapeutics, Metacrine, Nimbus Therapeutics